Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nabsolute is a Thai biotechnology startup spun off from the Faculty of Pharmaceutical Science at Chulalongkorn University. Founded in 2020, the company specializes in advanced drug delivery systems using its proprietary Hy-N™ Technology, a nano-modified biopolymer platform. This technology enhances the stability, solubility, and efficacy of active ingredients across the cosmetics, nutraceuticals, and pharmaceutical sectors. Nabsolute has gained international recognition, including winning the BSB Innovation Award at In-Cosmetics Global 2024, and is expanding its reach into the Chinese market through new cosmetic ingredient notifications. The company's research also extends to medical applications such as skin and bone restoration, osteoarthritis treatments, and vaccine delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NABSOLUTE.